Description de l'entreprise
Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries.
Conseil d'administration & Conseil de surveillance
PDG |
Kristin Peck |
Conseil d'administration |
Wetteny Joseph, Nick Ashton, Jamie Brannan, Heidi Chen, Rimma Driscoll, Jeannette Ferran Astorga, Roxanne Lagano, Wafaa Mamilli, Robert Polzer |
Conseil de surveillance |
Michael McCallister, Paul M. Bisaro, Vanessa Broadhurst, Frank D’Amelio, Sanjay Khosla, Antoinette R. Leatherberry, Gregory Norden, Louise M. Parent, Kristin Peck, Dr. Willie M. Reed, Dr. Linda Rhodes, Robert Scully |
Données de l'entreprise
Nom: |
Zoetis Inc. |
Adresse: |
10 Sylvan Way,Parsippany, New Jersey 07054, USA |
Téléphone: |
+1-973-822-7000 |
Fax: |
- |
Courriel: |
-
|
Internet: |
www.zoetis.com/ |
Industrie: |
Healthcare |
Secteur: |
Pharmaceutical Industry |
Sous-secteur: |
Pharmaceuticals |
Fin de l'exercice financier: |
31/12 |
Flotte libre: |
83.54% |
IPO date: |
01/02/2013 |
Relations avec les investisseurs
Nom: |
Steve Frank |
Téléphone IR: |
+1-973-822-7141 |
IR-Fax: |
- |
E-mail IR: |
steve.frank@zoetis.com
|